Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Dolby Laboratories, Inc. Director's Dealing 2023

Nov 24, 2023

30828_dirs_2023-11-24_893f3018-5e0b-4a35-bf63-0e5995a2485a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Dolby Laboratories, Inc. (DLB)
CIK: 0001308547
Period of Report: 2023-11-21

Reporting Person: YEAMAN KEVIN J (Director, President and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-11-21 Class A Common Stock M 45150 $42.98 Acquired 97029 Indirect
2023-11-21 Class A Common Stock S 9030 $83.9843 Disposed 87999 Indirect
2023-11-21 Class A Common Stock S 36120 $85.00 Disposed 51879 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-11-21 Employee Stock Option (Right to Buy) $42.98 M 45150 Disposed 2024-12-15 Class A Common Stock (45150) Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Class A Common Stock 119557 Direct

Footnotes

F1: The shares were sold in multiple transactions at prices ranging from $83.45 to $84.44. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

F2: Shares held following the reported transactions include 119,557 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.

F3: This option was granted for a total of 291,598 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date.